Lisa Walters-Hoffert - 01 Apr 2025 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Director
Signature
/s/ Melissa Tosca, Attorney-in-Fact
Issuer symbol
KPRX
Transactions as of
01 Apr 2025
Transactions value $
$0
Form type
4
Filing time
02 Apr 2025, 20:10:40 UTC
Previous filing
20 Aug 2024
Next filing
21 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPRX Stock Option (right to buy) Award $0 +20,000 $0 20,000 01 Apr 2025 Common Stock 20,000 $2.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026.